CVRX CVRx IncWatchlist
About CVRx Inc Company
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.
Craig-Hallum Releases a Buy Rating on CVRx (CVRX)
Craig Hallum Adjusts CVRx Price Target to $24 From $22, Maintains Buy Rating
CVRx (CVRX) has an average Buy rating and price target range of $17 to $24, according to analysts polled by Capital IQ.
CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference
MINNEAPOLIS, Nov. 15, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuro